The Medicines and Healthcare products Regulatory Agency (MHRA) has recommended that the obesity drug sibutramine (marketed as Reductil) should be suspended until further notice. This suspension was announced in January 2010 and follows a review by the European Medicines Agency. They have found that there is an increased risk of non-fatal heart attacks and strokes […]
Posts tagged “European Medicines Agency”
Obesity drug Reductil withdrawn from public use-8516
April 11th, 2011News Search
Categories
- Abortion
- Adoption
- Aesthetics Surgery
- Allergy
- Cancer
- Children's Health
- Contraception
- coronavirus
- Cosmetic dentistry
- Cosmetic surgery
- Dental
- Ear health
- Eye health
- Feminine Hygiene
- Fertility Treatment
- General Dental
- General Health
- Hair growth
- Hair loss
- Hair Removal
- Hair transplant
- Health insurance
- Hearing
- Heart Health
- HIV
- Infertility
- Medical Careers
- Medical negligence
- Mental Health
- New Discovery
- NHS
- Obesity
- Personal injury
- Skin health
- Sleep Disorders
- Stem cells
- Sugar
- Uncategorized
- Vaccines
- Weight loss